Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, nonmelanomatous (squamous and basal cell)
Trial Type:  Treatment
Results 1-16 of 16 for your search:
Start Over
Docetaxel, Cisplatin, and Cetuximab in Treating Patients With Metastatic or Relapsed Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: ENT0033, NCI-2011-03271, 22329, SU-08222011-8290, NCT01437449
Radiation Therapy and Vismodegib in Treating Patients With Locally Advanced Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CC #122011, NCI-2013-00871, 122011, NCT01835626
Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients with Basal Cell Nevus Syndrome
Status: Not yet active
Phase: Phase II
Type: Supportive care, Treatment
Age: Any age
Trial IDs: CASE 2614, NCI-2014-02037, NCT02258243, NCT02157623
Pegylated Interferon Alpha-2b and Capecitabine in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
Status: Temporarily closed
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MCC 17759, NCI-2014-01864, 14.06.0011, NCT02218164
Study for Treatment of Patients With Recurrent or Metastatic SCCHN or SCCS
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: TH-CR-602, NCI-2015-01845, NCT02449681
Stereotactic Radiosurgery in Treating Patients with Oligometastatic Disease
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-027, NCI-2014-01952, REN13120042, UPCI #10-027, NCT01345539
Stereotactic Radiosurgery in Treating Patients with Oligo-Recurrent Disease
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-028, NCI-2014-01953, REN13120040, UPCI# 10-028, NCT01345552
Pembrolizumab in Treating Patients with Rare Solid Tumors That Cannot Be Removed by Surgery or are Metastatic
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0948, NCI-2016-00545, NCT02721732
Photodynamic Therapy and Vismodegib in Treating Patients with Multiple Basal Cell Cancers
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 1511201549, NCI-2016-00096, ML28849, NCT02639117
Pembrolizumab with or without Vismodegib in Treating Skin Basal Cell Cancer That Is Metastatic or Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0031, NCI-2015-01869, 350, NCT02690948
Effectiveness of Narrow Margins in Patients with Low-Risk Basal Cell Carcinoma Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: Not specified
Trial IDs: 11D.479, NCI-2015-01624, 2011-68, NCT01903239
Itraconazole in Treating Patients with Basal Cell Carcinoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: J1299, NCI-2014-01255, NA_00077461, NCT02120677
Electronic Skin Surface Brachytherapy in Treating Older Patients with Newly Diagnosed Early Stage Basal Cell or Squamous Cell Skin Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 60 and over
Trial IDs: 14-001, NCI-2014-01090, NCT02131805
Erismodegib and Buparlisib in Treating Patients with Advanced or Metastatic Basal Cell Carcinoma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0020, NCI-2014-02200, 5136, NCT02303041
Cetuximab before Surgery in Treating Patients with Aggressive Locally Advanced Skin Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 091303, NCI-2014-02027, NCT02324608
Arsenic Trioxide and Itraconazole in Treating Patients with Advanced Basal Cell Cancer
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0033, NCI-2016-00180, NCT02699723
Start Over